Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study
Shria Kumar,David C Metz,Susan Ellenberg,David E Kaplan,David S Goldberg,David C. Metz,David E. Kaplan,David S. Goldberg
DOI: https://doi.org/10.1053/j.gastro.2019.10.019
IF: 29.4
2020-02-01
Gastroenterology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background & Aims</h3><p>Nearly all studies of gastric adenocarcinoma in the United States have relied on national cancer databases, which do not include data on <em>Helicobacter pylori</em> infection, the most well-known risk factor for gastric cancer. We collected data from a large cohort of patients in the United States to calculate the incidence of and risk factors for non-proximal gastric adenocarcinomas after detection of <em>H pylori</em>. Secondary aims included identifying how treatment and eradication affect cancer risk.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We performed a retrospective cohort study, collecting data from the Veterans Health Administration on 371,813 patients (median age, 62 years; 92.3% male) who received a diagnosis of <em>H pylori</em> infection from January 1, 1994 through December 31, 2018. The primary outcome was a diagnosis of distal gastric adenocarcinoma 30 days or more after detection of <em>H pylori</em> infection. We performed time to event with competing risk analysis (death before cancer a competing risk).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The cumulative incidence of cancer at 5, 10, and 20 years after detection of <em>H pylori</em> infection was 0.37%, 0.5%, and 0.65%, respectively. Factors associated with cancer included older age at time of detection of <em>H pylori</em> infection (sub-hazard ratio [SHR], 1.13; 95% CI, 1.11–1.15; <em>P</em><.001), black/African American race (SHR, 2.00; 95% CI, 1.80–2.22), Asian race (SHR, 2.52; 95% CI, 1.64–3.89) (<em>P</em><.001 for race), Hispanic or Latino ethnicity (SHR, 1.59; 95% CI, 1.34–1.87; <em>P</em><.001), or history of smoking (SHR, 1.38; 95% CI, 1.25–1.52; <em>P</em><.001). Women had decreased risk of gastric adenocarcinoma compared with men (SHR, 0.52; 95% CI, 0.40–0.68; <em>P</em><.001); patients whose <em>H pylori</em> infection was detected based on serum antibody positivity also had a reduced risk of cancer (SHR 0.74; 95% CI, 0.54-1.04; <em>P</em>=0.04). Patients who received treatment for their <em>H pylori</em> infection still had an increased risk of gastric cancer (SHR, 1.16; 95% CI, 0.74–1.83; <em>P</em>=.51), but confirmed <em>H pylori</em> eradication after treatment reduced risk of gastric cancer (SHR, 0.24; 95% CI, 0.15–0.41; <em>P</em><.001).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>In a study of 371,813 veterans with a diagnosis of <em>H pylori</em> infection, we found significantly higher risks of gastric cancer in racial and ethnic minorities and smokers. Treatment of <em>H pylori</em> infection only decreased risk if eradication was successful. Studies are needed on the effects of screening high-risk persons and to identify quality measures for diagnosis, resistance patterns, and treatment efficacy.</p>
gastroenterology & hepatology